Your browser doesn't support javascript.
loading
Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial.
Ailawadhi, S; Mikhael, J R; LaPlant, B R; Laumann, K M; Kumar, S; Roy, V; Dingli, D; Bergsagel, P L; Buadi, F K; Rajkumar, S V; Fonseca, R; Gertz, M A; Kapoor, P; Sher, T; Hayman, S R; Stewart, A K; Dispenzieri, A; Kyle, R A; Gonsalves, W I; Reeder, C B; Lin, Y; Go, R S; Leung, N; Kourelis, T; Lust, J A; Russell, S J; Chanan-Khan, A A; Lacy, M Q.
Affiliation
  • Ailawadhi S; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Mikhael JR; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • LaPlant BR; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Laumann KM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Kumar S; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Roy V; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Dingli D; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Bergsagel PL; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Buadi FK; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Rajkumar SV; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Fonseca R; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Gertz MA; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Kapoor P; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Sher T; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Hayman SR; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Stewart AK; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Dispenzieri A; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Kyle RA; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Gonsalves WI; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Reeder CB; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Lin Y; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Go RS; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Leung N; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Kourelis T; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Lust JA; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
  • Russell SJ; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Chanan-Khan AA; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Lacy MQ; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.
Leukemia ; 32(3): 719-728, 2018 03.
Article in En | MEDLINE | ID: mdl-28860655
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Drug Resistance, Neoplasm / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Drug Resistance, Neoplasm / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Type: Article Affiliation country: United States